CONSTANT INTRAPERITONEAL 5-FLUOROURACIL INFUSION THROUGH A TOTALLY IMPLANTED SYSTEM

被引：45
作者：
GYVES, JW
ENSMINGER, WD
STETSON, P
NIEDERHUBER, JE
MEYER, M
WALKER, S
JANIS, MA
GILBERTSON, S
机构：
[1] UNIV MICHIGAN, SCH MED, DEPT MED, DIV HEMATOL ONCOL, ANN ARBOR, MI 48109 USA
[2] UNIV MICHIGAN, SCH MED, DEPT PHARM, ANN ARBOR, MI 48109 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1984年 / 35卷 / 01期
关键词：
D O I：
10.1038/clpt.1984.12
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：83 / 89
页数：7
相关论文
共 31 条
[1]  
ACKERMAN NB, 1969, SURGERY, V66, P1067
[2]  
ALMERSJO O, 1976, ANN CHIR GYNAECOL FE, V65, P27
[3]  
ANSFIELD FJ, 1975, CANCER-AM CANCER SOC, V36, P2413, DOI 10.1002/1097-0142(197512)36:6<2413::AID-CNCR2820360621>3.0.CO
[4]  
2-3
[5]  
BROWN BW, 1977, STATISTICS BIOMEDICA
[6]   THRESHOLD METHOTREXATE CONCENTRATION FOR IN-VIVO INHIBITION OF DNA-SYNTHESIS IN NORMAL AND TUMOROUS TARGET TISSUES [J].
CHABNER, BA ;
YOUNG, RC .
JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (08) :1804-1811
[7]  
CLARKSON B, 1964, CLIN PHARMACOL THER, V5, P581
[8]   NON-LINEAR PHARMACOKINETIC MODELS FOR 5-FLUOROURACIL IN MAN - INTRAVENOUS AND INTRAPERITONEAL ROUTES [J].
COLLINS, JM ;
DEDRICK, RL ;
KING, FG ;
SPEYER, JL ;
MYERS, CE .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (02) :235-246
[9]  
DEDRICK RL, 1978, CANCER TREAT REP, V62, P1
[10]  
ENSMINGER W, 1983, P ASCO
1234